Schmidt et al. reported that BRCA1/2 mutation carriers who were diagnosed with breast cancer before the age of 50 years had worse OS that may be attributed to differences in tumor features, response to treatment, and secondary cancers [28]. The gene discussed is BRCA1; the disease is neoplasm.